Abstract
Mycotoxins are secondary fungal metabolites that can be produced in crops and other food commodities and may cause a mycotoxicosis in humans. The usual route of mycotoxin exposure is ingestion as food or feed contaminants. However, dermal and inhalation also may be important routes of exposure. Direct effects of mycotoxins range from an acute disease where severe conditions of altered health may exist prior to death as a result of exposure to the toxin. These conditions are more likely following exposure to high levels of mycotoxin. Other, more insidious or occult conditions or more chronic disease manifestations may result from prolonged exposure to small quantities of the toxin. The mycotoxins that pose the greatest potential risk to human and animal health are aflatoxins, trichothecenes, fumonisins, zearalenone, ochratoxin A, and ergot alkaloids. Awareness regarding the hazards of mycotoxins as contaminants of food and feed is growing, especially in the last decade.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- AFB1:
-
Aflatoxins B1
- IARC:
-
International Agency for Research on Cancer
- HBV:
-
Hepatitis B
- AFM1:
-
Aflatoxin M1
- DON:
-
Deoxynivalenol
- OTA:
-
Ochratoxin A
- BEN:
-
Balkan endemic nephropathy
- GI:
-
Gastrointestinal
- WDB:
-
Water-damaged buildings
- NAC:
-
N-Acetylcysteine
References
Forgacs J, Carll WT (1962) Mycotoxicoses. Adv Vet Sci 7:273–382
Council of Agricultural Science & Technology (CAST) (2003) Mycotoxins: risks in plant, animal and human systems. task force report No. 139. Council of Agricultural Science & Technology, Iowa, USA
Matossian MK (1989) Poisons of the past: molds, epidemics, and history. Yale University Press, New Haven, p 190
Van Rensburg SJ, Altenkirk B (1974) Claviceps purpurea: ergotism. In: IFH Purchase (ed) Mycotoxins. Elsevier, New York, pp 69–96
Alonso VA, Pereyra CM, Keller LA et al (2013) Fungi and mycotoxins in silage: an overview. J Appl Microbiol 115(3):637–643
Paterson RR, Lima N (2010) Toxicology of mycotoxins. EXS 100:31–63
Wambacq E, Vanhoutte I, Audenaert K, De Gelder L, Haesaert G (2016) Occurrence, prevention and remediation of toxigenic fungi and mycotoxins in silage: a review. J Sci Food Agric 96(7):2284–2302
Bryden WL (2007) Mycotoxins in the food chain: human health implications. Asia Pac J Clin Nutr 16(1):95–101
Marin S, Ramos AJ, Cano-Sancho G, Sanchis V (2013) Mycotoxins: occurrence, toxicology, and exposure assessment. Food Chem Toxicol 60:218–237
Ahmad M, Ahmad MM, Hamid R, Abdin MZ, Javed S (2013) Use of response surface methodology to study the effect of media composition on aflatoxin production by Aspergillus flavus. Mycotoxin Res 29(1):39–45
Wu HC, Santella R (2012) The role of aflatoxins in hepatocellular carcinoma. Hepat Mon 12(10):e7238
Leong YH, Latiff AA, Ahmad NI, Rosma A (2012) Exposure measurement of aflatoxins and aflatoxin metabolites in human body fluids. A short review. Mycotoxin Res 28(2):79–87
Bedard LL, Massey TE (2006) Aflatoxin B1-induced DNA damage and its repair. Cancer Lett 241(2):174–183
Wild CP, Turner PC (2002) The toxicology of aflatoxins as a basis for public health decisions. Mutagenesis 17(6):471–481
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (2002) Some traditional herbal medicines, some mycotoxins, naphthalene and styrene. IARC Monogr Eval Carcinog Risks Hum 82:1–556
Nordenstedt H, White DL, El-Serag HB (2010) The changing pattern of epidemiology in hepatocellular carcinoma. Dig Liver Dis 42(3):S206–S214
Anyanwu EC, Kanu I (2007) Biochemical impedance on intracellular functions of vitamin B12 in chronic toxigenic mold exposures. Sci World J 7:1649–1657
Staneva R, Rukova B, Hadjidekova S et al (2013) Whole genome methylation array analysis reveals new aspects in Balkan endemic nephropathy etiology. BMC Nephrol 14:225
Voss KA, Gelineau-vanWaes JB, Riley RT (2006) Fumonisins: current research trends in developmental toxicology. Mycotoxin Res 22:61–69
Yoshizawa T, Yamashita A, Luo Y (1994) Fumonisin occurrence in corn from high- and low-risk areas for human esophageal cancer in China. Appl Environ Microbiol 60(5):1626–1629
Bouhet S, Hourcade E, Loiseau N et al (2004) The mycotoxin fumonisin B1 alters the proliferation and the barrier function of porcine intestinal epithelial cells. Toxicol Sci 77:165–171
Dersjant-Li Y, Verstegen MWA, Gerrits WJJ (2003) The impact of low concentrations of aflatoxin, deoxynivalenol or fumonisins in diets on growing pigs and poultry. Nutr Res Rev 16:223–239
Pestka JJ, Zhou RR, Moon Y, Chung YJ (2004) Cellular and molecular mechanisms for immune modulation by deoxynivalenol and other tricothecenes; unraveling a paradox. Toxicol Lett 153:61–73
Riley RT, Enongene E, Voss KA et al (2001) Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis. Environ Health Perspect 109(2):301–308
Kuhn DM, Ghannoum MA (2003) Indoor mold, toxigenic fungi, and Stachybotrys chartarum: infectious disease perspective. Clin Microbiol Rev 16(1):144–172
Cullen JM, Newberne PM (1993) Acute hepatotoxicity of aflatoxins. In: Eaton DL, Groopman JD (eds) The toxicology of aflatoxins: human health, veterinary, and agricultural significance. Academic, London, pp 1–26
Eaton D, Ramsdell HS, Neal G (1993) Biotransformation of aflatoxins. In: Eaton D, Groopman JD (eds) The toxicology of aflatoxins: human health, veterinary, and agricultural significance. Academic, London, pp 45–72
Vargas EA, Preis RA, Castro L, Silva CM (2001) Co-occurrence of aflatoxins B1, B2, G1, G2, zearalenone and fumonisin B1 in Brazilian corn. Food Addit Contam 18:981–986
Henry SH, Bosch FX, Bowers JC (2002) Aflatoxin, hepatitis and worldwide liver cancer risks. Adv Exp Med Biol 504:229–233
Gong Y, Cardwell K, Hounsa A et al (2002) Dietary aflatoxin exposure and impaired growth in children from Beninand Togo: Cross sectional study. Br Med J 325:20–21
Elsasser TJ, Klasing KC, Filipov N, Thompson F (2000) The metabolic consequences of stress: targets for stress and priorities of nutrient use. In: Moberg GP, Mench JA (eds) The biology of animal stress. CABI Publishing, New York, pp 77–110
Hendrickse RC (1991) Kwashiokor: the hypothesis that incriminates aflatoxin. Paediatrics 88:376–379
Oswald IP, Marin DE, Bouhet S, Pinton P, Taranu I, Accensi F (2005) Immunotoxicological risk of mycotoxins for domestic animals. Food Addit Contam 22:354–360
Bondy G, Pestka JJ (2000) Immunomodulation by fungal toxins. J Toxicol Environ Health 3:109–143
Turner PC, Moore SE, Hall AJ, Prentice AM, Wild CP (2003) Modification of immune function through exposure to dietary aflatoxin in Gambian children. Environ Health Perspect 111:217–220
Jiang YI, Jolly PE, Ellis WO, Wang JS, Phillips TD, Williams JH (2005) AflatoxinB1 albumin adduct levels and cellular immune status in Ghanaians. Int Immunol 17:807–814
Chuang SC, La Vecchia C, Boffetta P (2009) Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection. Cancer Lett 286:9–14
Llovet JM, Burroughs A, Bruix J (2003) Hepatocellular carcinoma. Lancet 362:1907–1917
Gomaa AI, Khan SA, Toledano MB, Waked I, Taylor-Robinson SD (2008) Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis. World J Gastroenterol 14:4300–4308
Matsuda Y, Ichida T, Fukumoto M (2011) Hepatocellular carcinoma and liver transplantation: clinical perspective on molecular targeted strategies. Med Mol Morphol 44:117–124
Stiborova M, Arlt VM, Schmeiser HN (2016) Balkan endemic nephropathy: an update on its aetiology. Arch Toxicol 90(11):2595–2615
Anandagoda N, Lord GM (2015) Preventing aristolochic acid nephropathy. Clin J Am Soc Nephrol 10:167–168
Schmeiser HH, Kucab JE, Arlt VM et al (2012) Evidence of exposure to aristolochic acid in patients with urothelial cancer from a Balkan endemic nephropathy region of Romania. Environ Mol Mutagen 53:636–641
Stefanovic V, Toncheva D, Polenakovic M (2015) Balkan nephropathy. Clin Nephrol 83(1):64–69
Pfohl-Leszkowicz A (2009) Ochratoxin A and aristolochic acid involvement in nephropathies and associated urothelial tract tumours. Arh Hig Rada Toksikol 60:465–483
Mantle PG, Faucet-Marquis V, Manderville RA, Squillaci B, Pfohl-Leszkowicz A (2010) Structures of covalent adducts between DNA and ochratoxin A: a new factor in debate about genotoxicity and human risk assessment. Chem Res Toxicol 23:89–98
Pinton P, Braicu C, Nougayrede JP, Laffitte J, Taranu I, Oswald IP (2010) Deoxynivalenol impairs porcine intestinal barrier function and decreases the protein expression of claudin-4 through a mitogen activated protein kinase-dependent mechanism. J Nutr 140:1956–1962
Grenier B, Applegate TJ (2013) Modulation of intestinal functions following mycotoxin ingestion: meta-analysis of published experiments in animals. Toxins 5:396–430
Maresca M, Fantini J (2010) Some food associated mycotoxins as potential risk factors in humans predisposed to chronic intestinal inflammatory diseases. Toxicon 56:282–294
Eduard W (2009) Fungal spores: a critical review of the toxicological and epidemiological evidence as a basis for occupational exposure limit setting. Crit Rev Toxicol 39(10):799–864
Lichtenstein JH, Molina RM, Donaghey TC et al (2010) Pulmonary responses to Stachybotrys chartarum and its toxins: mouse strain affects clearance and macrophage cytotoxicity. Toxicol Sci 116(1):113–121
Liu C, Shen H, Yi L et al (2015) Oral administration of aflatoxin G(1) induces chronic alveolar inflammation associated with lung tumorigenesis. Toxicol Lett 232(3):547–556
Thrasher JD, Gray MR, Kilburn KH, Dennis D, Yu A (2012) A water-damaged home and health of occupants: A case study. J Environ Public Health 2012:312836
Brasel TL, Campbell AW, Demers RE et al (2004) Detection of trichothecene mycotoxins in sera from individuals exposed to Stachybotrys chartarum in indoor environments. Arch Environ Health 59:317–323
Layton RC, Purdy CW, Jumper CA, Straus DC (2009) Detection of macrocyclic trichothecene mycotoxins in a caprine (goat) tracheal instillation model. Toxicol Ind Health 25:693–701
Enongene EN, Sharma RP, Bhandari N, Voss KA, Riley RT (2000) Disruption of sphingolipid metabolism in small intestines, liver and kidney of mice dosed subcutaneously with fumonisin B (1). Food Chem Toxicol 38(9):793–799
Samaranayake LP (1986) Nutritional factors and oral candidosis. J Oral Pathol 15(2):61–65
Hitzig WH (1983) Protean appearances of immunodeficiencies: syndromes and inborn errors involving other systems, which express associated primary immunodeficiency. Birth Defects 19(3):307–312
Graeme KA (2014) Mycetism: a review of the recent literature. J Med Toxicol 10:173–189
Rogan WJ, Yang GC, Kimbrough RD (1985) Aflatoxin and Reye’s syndrome: a study of livers from deceased cases. Arch Environ Health 40(2):91–95
Kirchmair M, Carrilho P, Pfab R et al (2012) Amanita poisoning resulting in acute, reversible renal failure: new cases, new toxic Amanita mushrooms. Nephrol Dial Transplant 27:1380–1386
Mendez-Navarro J, Ortiz-Olivera NX, Villegas-Rios M et al (2011) Hepatotoxicity from ingestion of wild mushrooms of the genus Amanita section Phalloideae collected Mexico City: two case reports. Ann Hepatol 10(4):568–574
French LK, Hendrickson RG, Horowitz BZ (2011) Amanita phalloides poisoning. Clin Toxicol 49:128–129
Hawksworth DL, Wiltshire PEJ (2011) Forensic mycology: the use of fungi in criminal investigations. Forensic Sci Int 206:1–11
Eren SH, Demirel Y, Ugurlu S, Korkmaz I, Aktas C, Guven FM (2010) Mushroom poisoning: retrospective analysis of 294 cases. Clinics 65(5):491–496
Lima ADL, Costa Fortes R, Carvalho Garbi Novaes MR, Percario S (2012) Poisonous mushrooms: a review of the most common intoxications. Nutr Hosp 27(2):402–408
Lukasik-Glebocka M, Druzdz A, Naskret M (2011) Clinical symptoms and circumstances of acute poisoning with fly agaric (Amanita muscaria) and panther cap (Amanita pantherina). Przegl Lek 68(8):449–452
Pauli JL, Foot CL (2005) Fatal muscarinic syndrome after eating wild mushrooms. Med J Aust 182:294–295
Karlson-Stiber C, Persson H (2003) Cytotoxic fungi-an overview. Toxicon 2(4):339–349
Michelot D, Toth B (1991) Poisoning by Gyromitra esculenta-a review. J Appl Toxicol 11(4):235–243
Lheureux P, Penaloza A, Gris M (2005) Pyridoxine in clinical toxicology: a review. Eur J Emerg Med 12:78–85
Gejyo F, Homma N, Higuchi N et al (2005) A novel type of encephalopathy associated with mushroom Sugihiratake ingestion in patients with chronic kidney diseases. Kidney Int 68(1):188–192
Kuwabara T, Arai A, Honma N, Nishizawa M (2005) Acute encephalopathy among patients with renal dysfunction after ingestion of “sugihiratake”, angel’s wing mushroom—study on the incipient cases in the northern area of Niigata Prefecture. Rinsho Shinkeigaku 45(3):239–245
Saviuc P, Danel V (2006) New syndromes in mushroom poisoning. Toxicol Rev 25(3):199–209
Satora L, Goszcz H, Ciszowski K (2005) Poisonings resulting from the ingestion of magic mushrooms in Krakow. Przegl Lek 62(6):394–396
Kurokawa K, Sato H, Nakajima K, Kawanami T, Kato T (2005) Clinical, neuroimaging and electroencephalographic findings of encephalopathy occurring after the ingestion of “sugihiratake” (Pleurocybella porrigens), an autumn mushroom: a report of two cases. Rinsho Shinkeigaku 45(2):111–116
Zhang Y, Li Y, Wu G et al (2012) Evidence against barium in the mushroom Trogia venenata as a cause of sudden unexpected death in Yunnan, China. Appl Environ Microbiol 78(24):8834
Shi GQ, Huang WL, Zhang J et al (2012) Clusters of sudden unexplained death associated with the mushroom, Trogia venenata, in rural Yunnan. PLoS ONE 7(5):e35894
Santi L, Maggioli C, Mastroroberto M, Tufoni M, Napoli L, Caraceni P (2012) Acute liver failure caused by Amanita phalloides poisoning. Int J Hepatol 2012:48748
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Barac, A. (2019). Mycotoxins and Human Disease. In: Presterl, E. (eds) Clinically Relevant Mycoses. Springer, Cham. https://doi.org/10.1007/978-3-319-92300-0_14
Download citation
DOI: https://doi.org/10.1007/978-3-319-92300-0_14
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-92299-7
Online ISBN: 978-3-319-92300-0
eBook Packages: MedicineMedicine (R0)